Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec;35(12):e15912.
doi: 10.1111/dth.15912. Epub 2022 Oct 17.

Cyclosporine-induced gingival overgrowth-Review

Joanna Chojnacka-Purpurowicz  1 , Ewa Wygonowska  1 , Waldemar Placek  1 , Agnieszka Owczarczyk-Saczonek  1
Affiliations
Review

Cyclosporine-induced gingival overgrowth-Review

Joanna Chojnacka-Purpurowicz et al. Dermatol Ther. 2022 Dec.

Abstract

Drug-induced gingival overgrowth (DIGO) is an undesirable effect resulting from the therapy of one of the three groups of drugs: phenytoin, calcium channel blockers, and cyclosporine A (CsA). It is caused by a fibrous overgrowth leading to gingivitis, periodontitis, and even tooth loss. Possible consequences include tooth decay worsening, pain and difficulty in eating, bleeding gums, and bad breath. The pathomechanism of the hypertrophy is unknown, but there is a correlation between insufficient oral hygiene and the severity of this phenomenon. The gender and age predilection of gingival hyperplasia as a result of CsA therapy is also noticeable. It is most common in children and adolescents of the male sex. The beneficial effect of the removal of tartar and local irritants in reducing the above symptoms has been demonstrated. One of the treatments for DIGO is conventional gingivectomy. The paper is a review article about cyclosporine-induced gingival hyperplasia.

Keywords: DIGO; calcineurin inhibitor; cyclosporine; gingival overgrowth; gingivectomy.

PubMed Disclaimer

References

REFERENCES

    1. Torrezan PR, Andrade Sobrinho J, Denardin OV, Rapoport A. Hipertrofia gengival em transplantados renais [cyclosporine induced gingival hyperplasia in kidney transplants]. Rev Assoc Med Bras. 2005;51(4):200-205. doi:10.1590/s0104-42302005000400015
    1. Ricardo LH, do Prado RF, Carvalho YR, da Silva Peralta F, Pallos D. Cyclosporine A-induced gingival overgrowth and proliferating cell nuclear antigen expression in experimental periodontitis. J Oral Biol Craniofac Res. 2019;9(1):86-90. doi:10.1016/j.jobcr.2018.10.004
    1. Amor KT, Ryan C, Menter A. Zastosowanie cyklosporyny w dermatologii. Część I. Dermatologia po Dyplomie. 2011;2(3):7-34.
    1. Amber T, Tabassum S. Cyclosporin in dermatology: a practical compendium. Dermatol Ther. 2020 Nov;33(6):e13934. doi:10.1111/dth.13934
    1. Ryan C, Amor KT, Menter A. Zastosowanie cyklosporyny w dermatologii. Część II. Dermatologia po Dyplomie. 2011;2(4):7-35.

LinkOut - more resources